Furthermore, patients with increased PD-L1 expression, either soluble or within the tumor itself, had poorer response to treatment and lower survival rates; PD-L1 expression was found to be an independent adverse prognostic factor for patients with stage I to II NK T cell lymphomas (164). This evidence concerns the gene CD274 and neoplasm.